These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22863800)

  • 41. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between mucoadhesive polymers and surface coating in tablets for the controlled colonic delivery of a poorly water-soluble drug.
    Phan TQ; Tran PHL; Tran TTD
    Daru; 2020 Dec; 28(2):545-553. PubMed ID: 32705542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin B12 buccoadhesive tablets: auspicious non-invasive substitute for intra muscular injection: formulation, in vitro and in vivo appraisal.
    Mohamad SA; Abdelkader H; Elrehany M; Mansour HF
    Drug Dev Ind Pharm; 2019 Feb; 45(2):244-251. PubMed ID: 30289003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
    Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of excipient and processing variables on adhesive properties and release profile of pentoxifylline from mucoadhesive tablets.
    Surapaneni MS; Das SK; Das NG
    Drug Dev Ind Pharm; 2006 Mar; 32(3):377-87. PubMed ID: 16556542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and in vitro evaluation of buccoadhesive carvedilol tablets.
    Yamsani VV; Gannu R; Kolli C; Rao ME; Yamsani MR
    Acta Pharm; 2007 Jun; 57(2):185-97. PubMed ID: 17507315
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Swelling of hydroxypropyl methylcellulose matrix tablets. 2. Mechanistic study of the influence of formulation variables on matrix performance and drug release.
    Gao P; Skoug JW; Nixon PR; Ju TR; Stemm NL; Sung KC
    J Pharm Sci; 1996 Jul; 85(7):732-40. PubMed ID: 8818998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development and evaluation of gastroretentive norfloxacin floating tablets.
    Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
    Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural gum as mucoadhesive controlled release carriers: evaluation of cefpodoxime proxetil by D-optimal design technique.
    Patil SH; Talele GS
    Drug Deliv; 2014 Mar; 21(2):118-29. PubMed ID: 24032629
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Captopril floating and/or bioadhesive tablets: design and release kinetics.
    Nur AO; Zhang JS
    Drug Dev Ind Pharm; 2000 Sep; 26(9):965-9. PubMed ID: 10914320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
    Liu H; Pan W; Ke P; Dong Y; Ji L
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study.
    Sankar R; Jain SK
    Drug Des Devel Ther; 2013; 7():1455-69. PubMed ID: 24348022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F; Mansourpour Z; Mortazavian E; Rafiee-Tehrani N; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2017 Dec; 121():61-72. PubMed ID: 28951063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.
    Malik NS; Ahmad M; Alqahtani MS; Mahmood A; Barkat K; Khan MT; Tulain UR; Rashid A
    Drug Deliv; 2021 Dec; 28(1):1093-1108. PubMed ID: 34114907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development and evaluation of buccoadhesive controlled release tablets of lercanidipine.
    Charde S; Mudgal M; Kumar L; Saha R
    AAPS PharmSciTech; 2008; 9(1):182-90. PubMed ID: 18446480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride.
    Gil EC; Colarte AI; Bataille B; Pedraz JL; Rodríguez F; Heinämäki J
    Int J Pharm; 2006 Jul; 317(1):32-9. PubMed ID: 16584856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.